2126 — JW (Cayman) Therapeutics Co Balance Sheet
0.000.00%
- HK$581.75m
- HK$57.12m
- CNY173.86m
Annual balance sheet for JW (Cayman) Therapeutics Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 255 | 2,631 | 1,834 | 1,383 | 1,006 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 2.86 | 29.4 | 0 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 261 | 2,647 | 1,895 | 1,485 | 1,067 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 222 | 309 | 381 | 394 | 343 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 669 | 3,779 | 3,117 | 2,791 | 2,146 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 123 | 237 | 199 | 311 | 264 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1,611 | 350 | 326 | 437 | 462 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | -942 | 3,430 | 2,791 | 2,354 | 1,684 |
Total Liabilities & Shareholders' Equity | 669 | 3,779 | 3,117 | 2,791 | 2,146 |
Total Common Shares Outstanding |